SNYNF:OTCMKTS
Sanofi SA
78,17 USD
arrow_upward
+1,84%(+1,41) 1 D.
10-14, 16:00:00 GMT−4 · USD
search
Visi simboliai
| Simbolis | Kaina | Keisti | Pokytis, % |
|---|
insights_autoGeneruojamos svarbiausios „SNYNF“ įžvalgos...
Atidaryti
81,34 USD
Aukšta
81,34 USD
Žema
78,17 USD
Rinkos kapitalizacija
96,87 mlrd.
Vid. kiekis
5,47 tūkst.
Apimtis
778,00
52 sav. aukšta
106,34 USD
52 sav. žema
76,76 USD
Beta
0,32
Neapmokėtos akcijos
1,21 mlrd.
Darbuotojų skaičius
75 tūkst.
Atidaryti
81,34 USD
Aukšta
81,34 USD
Žema
78,17 USD
Rinkos kapitalizacija
96,87 mlrd.
Vid. kiekis
5,47 tūkst.
Apimtis
778,00
52 sav. aukšta
106,34 USD
52 sav. žema
76,76 USD
Beta
0,32
Neapmokėtos akcijos
1,21 mlrd.
Darbuotojų skaičius
75 tūkst.
Naujienų istorijos
Iš žiniatinklio šaltinių ir naujienų partnerių
TipRanks
·
prieš 4 valandas
Sanofi’s RSV Study in Queensland Offers Fresh Clues on Nirsevimab Uptake
Yahoo Finance
·
prieš 5 valandas
Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?
Endpoints News
·
prieš 6 valandas
Ultragenyx’s second PRV sale; Biomea’s oral GLP-1 data leads to stock slump
Euronext Markets: Real-time Stock Market Data | live
·
prieš 7 valandas
Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine
Profilis
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Apie „Sanofi SA“
Generalinis direktoriusPaul Hudson | Belén Garijo
Darbuotojai74,8 tūkst.
Įkurta1973
Pagrindinė būstinėParyžius, Il-de-Fransas, Prancūzija
Sektorius-
Svetainėsanofi.com